表紙
市場調査レポート

耐糖能異常に関する世界の治験レビュー

Glucose Intolerance Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 217229
出版日 ページ情報 英文 78 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
耐糖能異常に関する世界の治験レビュー Glucose Intolerance Global Clinical Trials Review, H1, 2014
出版日: 2014年04月30日 ページ情報: 英文 78 Pages
概要

耐糖能異常は糖尿病予備軍であり、血糖値が正常値を超えてはいるものの糖尿病と診断するに満たないものをいいます。インスリン耐性に関連し、心血管疾患のリスクが上がります。20歳〜79歳の耐糖能異常(IGT)は世界の3億4,400万人、人口の7.9%を占め、2030年までに4億7,200万人、8.4%に増加すると予測されています。

当レポートでは、世界の2011年下半期の耐糖能障害に関する治験動向について調査し、地域別、段階別に分析し、開発中の薬剤の概要、1982年から2011年9月現在の70の登録薬剤について紹介し、概略以下の構成でお届けします。

目次

イントロダクション

地域別治験

  • 国別治験
    • アジア太平洋地域
    • 欧州
    • 北米
    • 中東・アフリカ
    • 中南米
  • BRIC諸国
  • G7諸国
  • 治験状況別G7の治験
  • E7諸国
  • 治験状況別E7の治験
  • 段階別治験
  • 未達成治験
  • 一定期間内に募集した被験者
  • 主な治験依頼者
    • 耐糖能障害治験に参画する主な企業
  • 薬剤比較
  • 治験プロファイル
    • 主要企業
      • Merck & Co., Inc
      • Novartis
      • 塩野義製薬
    • 大学・機関・病院
      • Yale University
      • Seattle Institute for Biomedical and Clinical Research
      • Hadassah Medical Organization
      • University of Oslo
      • The National Institute of Diavetes and Digestive Kidney Disease
      • University of Leipzig
      • University of Sherbrooke
      • 東京大学
      • Northwestern University
      • Hillel Yaffe Medical Center
      • University of California, Los Angeles
      • Gentofte University Hospital
      • University of Copenhagen
      • Tel-Aviv Sourasky Medical Center
      • University Hospital Tubingen
      • University of Missouri
      • Emory University
      • University of Oxford
      • University of Miami
      • Lawson Health Research Institute

5つの主要な治験プロファイル

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2115CTIDB

GlobalData's clinical trial report, "Glucose Intolerance Global Clinical Trials Review, H1, 2014" provides data on the Glucose Intolerance clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Glucose Intolerance. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Glucose Intolerance. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Glucose Intolerance
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Glucose Intolerance
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Glucose Intolerance Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Genfit SA
      • Clinical Trial Overview of Genfit SA
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • N-Gene Research Laboratories, Inc.
      • Clinical Trial Overview of N-Gene Research Laboratories, Inc.
      • Laboratoires Stella SA
      • Clinical Trial Overview of Laboratoires Stella SA
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
    • Clinical Trial Overview of Top Institutes / Government
      • Yale University
      • Clinical Trial Overview of Yale University
      • The National Institute of Diabetes and Digestive and Kidney Diseases
      • Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
      • Hadassah Medical Organization
      • Clinical Trial Overview of Hadassah Medical Organization
      • Maastricht University Medical Center
      • Clinical Trial Overview of Maastricht University Medical Center
      • University of Oslo
      • Clinical Trial Overview of University of Oslo
      • Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Universite de Sherbrooke
      • Clinical Trial Overview of Universite de Sherbrooke
      • Academic Medical Center
      • Clinical Trial Overview of Academic Medical Center
      • University of Tasmania
      • Clinical Trial Overview of University of Tasmania
      • Chinese University of Hong Kong
      • Clinical Trial Overview of Chinese University of Hong Kong
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Glucose Intolerance Therapeutics, Global, Clinical Trials by Region, 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014*
  • Glucose Intolerance Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Glucose Intolerance Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014*
  • Glucose Intolerance Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Glucose Intolerance Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Glucose Intolerance Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Glucose Intolerance Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Genfit SA, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by N-Gene Research Laboratories, Inc., 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Stella SA, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oslo, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Universite de Sherbrooke, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Tasmania, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014*

List of Figures

  • Glucose Intolerance Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014*
  • Glucose Intolerance Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Glucose Intolerance Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014*
  • Glucose Intolerance Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Glucose Intolerance Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Glucose Intolerance Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top